Pre-transplant Loco-Regional Therapy for Hepatocellular Carcinoma and Post-transplant Outcomes: A National Study.

Cureus · 2024 · PMC11427028 · PMID 39328600

Europe PMC DOI

hedged sentence

0.2600

closest p · 5.2× alpha

0.2600

boldest claim

The sentences

showed a trendp=0.26not close (p > 0.1)

did not reach statistical significanceno p-value reported

In contrast, combination treatment with TACE + RFA showed a trend towards improved survival compared with no treatment (67.1% vs 63.3%, p=0.26, Figure 5 ) but did not reach statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.